Vimarsana
Biggest News Aggregation in the World

Page 24 - Twist Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Twist Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Twist Bioscience Today - Breaking & Trending Today

Twist Bioscience to Present at Upcoming Investor Conferences - Vimarsana News

Twist Bioscience to Present at Upcoming Investor Conferences

Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D.,...

Is Saia (SAIA) a Worthy Investment? - Insider Monkey - Vimarsana News

Is Saia (SAIA) a Worthy Investment? - Insider Monkey

Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” second quarter 2023 investor letter. A copy of the same can be downloaded here.

Twist Bioscience Enters into Agreement with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune Diseases - Vimarsana News

Twist Bioscience Enters into Agreement with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune Diseases

Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a drug discovery agreement with...

Should You Add Twist Bioscience Corporation (TWST) to Your Portfolio? - Vimarsana News

Should You Add Twist Bioscience Corporation (TWST) to Your Portfolio?

Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” second quarter 2023 investor letter. A copy of the same can be downloaded here. In the second quarter, its Investor Class fund ARTSX returned 1.10%, Advisor Class fund APDSX posted a return of 1.19%, and Institutional Class fund APHSX returned 1.19%, compared to a […]

Source: yahoo.com
Oligonucleotide Synthesis Market worth $3.97 Billion by - Vimarsana News

Oligonucleotide Synthesis Market worth $3.97 Billion by

Global oligonucleotide synthesis market is growing at a CAGR of 11.1% from 2019 to 2027....